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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYDirect cell reprogramming enables direct conversion of fibroblasts into functional neurons and oligodendrocytes using a minimal set of
cell-lineage-specific transcription factors. This approach is rapid and simple, generating the cell types of interest in one step. However, it
remains unknownwhether this technology can be applied to convert fibroblasts into astrocytes, the third neural lineage. Astrocytes play
crucial roles in neuronal homeostasis, and their dysfunctions contribute to the origin and progression of multiple human diseases. Here-
in, we carried out a screening using several transcription factors involved in defining the astroglial cell fate and identifiedNFIA, NFIB, and
SOX9 to be sufficient to convert with high efficiency embryonic and postnatal mouse fibroblasts into astrocytes (iAstrocytes). We proved
both by gene-expression profiling and functional tests that iAstrocytes are comparable to native brain astrocytes. This protocol can be
then employed to generate functional iAstrocytes for a wide range of experimental applications.INTRODUCTION
Direct cell-reprogramming technology is based on the
dominant action of cell-lineage transcription factors (TFs)
in converting adult somatic cells into different cell types
(Graf and Enver, 2009). This technique represents a prom-
ising avenue in the field of regenerative medicine, with the
potential to generate cellular sources suitable for cell-
replacement therapies (Chambers and Studer, 2011). In
fact, since the groundbreaking discovery of the induced
pluripotent stem cells (iPSCs) (Takahashi and Yamanaka,
2006), increasing approaches of direct cell reprogramming
have been established, culminating with the development
of induced cellular types for neurons, cardiomyocytes, and
hepatocytes (Vierbuchen et al., 2010; Ieda et al., 2010;
Huang et al., 2011). In addition, we and others employed
the forced expression of defined sets of TFs to generate spe-
cific induced neuronal sublineages for dopaminergic,
cholinergic, and motor neurons (Caiazzo et al., 2011; Pfis-
terer et al., 2011; Kim et al., 2002; Son et al., 2011; Liu
et al., 2013; Theka et al., 2013). More recently, two groups
succeeded in the generation of induced oligodendrocyte
precursors by direct conversion of fibroblasts (Najm et al.,
2013; Yang et al., 2013). Surprisingly, to date, there is noStemreport for the generation of astrocyte by means of direct
cell reprogramming. Astrocytes are the most-abundant
cell type in the CNS and a critical neural cell type respon-
sible for the maintenance of brain homeostasis. Indeed,
they play irreplaceable roles in neurotransmitter trafficking
and recycling, nutrient and ion metabolism, regulation of
blood supply, release of transmitters and growth factors,
and protection against oxidative stress (Molofsky et al.,
2012). Consistent with such a variety of fundamental func-
tions exerted by astrocytes in supporting neuronal survival
and function, astrocyte dysfunctions have been found to
contribute to several neurological diseases, such as epi-
lepsy, amyotrophic lateral sclerosis (ALS), Alzheimer’s dis-
ease, lysosomal storage diseases (Di Malta et al., 2012),
and Rett syndrome (Molofsky et al., 2012). Conversely,
recent data showed that transplanted astrocyte progenitors
display robust survival and differentiation in the host brain
and are able to decelerate the disease course in ALS and Alz-
heimer’s disease models (Lepore et al., 2008; Pihlaja et al.,
2008). However, current protocols rely on the isolation of
astrocyte progenitors from neonatal brains with serious
limitations for any therapeutic approach as the paucity of
cell supply and unmatched immunoprofile with the host,
leading to immune reaction and possible rejection afterCell Reports j Vol. 4 j 25–36 j January 13, 2015 j ª2015 The Authors 25
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nerating astrocytes starting from adult skin fibroblasts
from an immunomatched or autologous source, can repre-
sent a promising alternative system for overcoming those
bottlenecks. Notably, procedures of direct iPSC differentia-
tion into astrocytes have been established only very
recently (Krencik et al., 2011; Emdad et al., 2012; Juopperi
et al., 2012; Roybon et al., 2013; Serio et al., 2013; Shaltouki
et al., 2013). However, these approaches rely on the previ-
ous generation of stable and mutation-free iPSC lines, and
the cell differentiation protocols are considerably time-
consuming, complex, and required extensive time up to
180 days. We therefore considered that a direct repro-
gramming approach could have interesting advantages,
providing a more practical procedure to generate astro-
cyte-like cells. Indeed, after the identification of the reprog-
ramming cocktail composed by the astroglial TFs NFIA,
NFIB, and SOX9, we defined a straightforward and fast
(2 weeks) protocol to generate induced astrocytes (iAstro-
cytes) derived from mouse embryonic and postnatal fibro-
blasts. Our experiments indicate that iAstrocyte molecular
phenotype and biological functions closely recapitulate
that of native astrocytes, thus validating the direct reprog-
ramming technology as an alternative for the generation of
astrocytes.RESULTS
Defining the Minimal Set of TFs Able to Convert
Fibroblasts to an Astrocytic Cell Fate
To generate iAstrocytes, we initially performed a literature
data mining for selecting a first pool of eight candidate
TFs known to play relevant roles in astrocyte differentia-
tion and maintenance during nervous system develop-
ment (Rowitch, 2004; Deneen et al., 2006; Rowitch and
Kriegstein, 2010). In addition, we added six additional
candidate TFs that exhibit a selective expression in astro-
cytes when compared to the global gene-expression pro-
files of neurons and oligodendrocytes (Lovatt et al., 2007;
Cahoy et al., 2008; Doyle et al., 2008; Najm et al., 2013).
Thus, we selected a total of 14 TFs (SOX2, SOX9, PAX6,
NKX6.1, OLIG1, OLIG2, NFIA, NFIB, NFIX, HES1, HES5,
NICD, TAL1, and PRDM16). Their coding regions were
individually cloned into doxycycline (dox)-inducible lenti-
viral vectors, and each lentivirus was used to infect mouse
embryonic fibroblasts (MEFs). The day after the infection,
MEF culture medium was replaced with fresh medium sup-
plemented with dox. After 12 days of dox exposure, the
activation of the well-known astrocyte markers GFAP and
S100B was assessed by immunostaining in the infected
cell culture. Interestingly, only NFIA, NFIB, and SOX9
among all 14 candidate TFs induced a significant amount26 Stem Cell Reports j Vol. 4 j 25–36 j January 13, 2015 j ª2015 The Authorof S100B-positive cells, as well as a relative smaller number
of GFAP-positive cells. On the contrary, GFP infected or not
infected (control) MEFs did not show any relevant expres-
sion of these two astrocyte-specific markers (Figure S1A
available online). In order to confirm the presence of
GFAP-positive cells and develop a system for isolating
them, we set up a genetic cell-fate-tracing method selective
for the astrocyte cell lineage by using MEFs derived from
the hGFAP-Cre;ROSA26-stop-flox-yellow fluorescent pro-
tein (YFP) double-transgenic mice. Fluorescence-activated
cell sorting (FACS) analysis confirmed the presence of
YFP-positive cells after infection with NFIA, NFIB, or
SOX9 (data not shown). We then combined the three fac-
tors NFIA, NFIB, and SOX9 (hereafter abbreviated as A, B,
and S9) in different groups for identifying the most-per-
forming combination in giving the highest efficiency of
astrocyte conversion. Among all the possible factor combi-
nations (AB, AS9, BS9, and ABS9), ABS9 cocktail generated
the largest number of GFAP- and S100B-positive cells, as
shown in Figures S1B–S1D. We confirmed this finding
also by FACS analysis using the hGFAP-Cre;ROSA26-stop-
flox-YFP double-transgenic MEFs, estimating in 15% the
total number of YFP-positive cells (Figures 1A and S1D).
Importantly, no other factor added to this combination
enabled any evident increase of the reprogrammed cell
number (data not shown), concluding that ABS9 is the
minimal and sufficient set of TFs eliciting a sustained con-
version ofMEFs into iAstrocytes. Closer inspection of ABS9
iAstrocytes confirms their round cell shape, resembling so-
matic astrocyte morphology and the coexpression of both
theGFAP and S100B proteins in a vast fraction of them (Fig-
ures 1B, 1C, 1E, 1F, and 1H). Conversely, very few (<0.2%)
S100B-positive cells and no GFAP-positive cells were de-
tected in the GFP-transduced cell population (Figures 1D
and 1G). As shown in Figure 1I, iAstrocytes also expressed
high levels of the main astrocytic glutamate transporter
GLT-1 (National Center for Biotechnology Information:
SLC1A2). Quantitative studies determined that infected
MEFs activated S100B in high numbers (21%) and that
GFAP (16%) and GLT-1 (11%) were found in large sub-
groups of cells always colocalizing with S100B (Figure 1J;
data not shown).
In order to characterize the dynamics involved in iAstro
reprogramming, we analyzed the conversion at different
time points by immunostaining and quantitative RT-
PCR (qRT-PCR). The results of this experiment showed
that neither OCT4 nor SOX2 proteins are ever expressed
(data not shown) and also the transcriptional analysis
did not detect any other embryonic stem cell (ESC) or
neural stem cell (NSC) marker, with the only exception
of Tlx and Pax6 that are minimally increased only at day
1 of the reprogramming protocol (Figures S2A–S2I). These
results indicate that iAstro-reprogramming process iss
Figure 1. NFIA, NFIB, and SOX9 Effi-
ciently Reprogram Mouse Fibroblasts
into iAstrocytes
(A) Schematic representation of the one-
step differentiation protocol. DIV, days
in vitro.
(B–D) Analysis of GFAP immunoreactivity in
reprogrammed and control (noninfected
[NI]) fibroblasts (d, days after infection).
(E–G) Analysis of S100B immunoreactivity in
reprogrammed and control fibroblasts.
(H) Coimmunostaining of GFAP and S100B in
iAstrocytes.
(I) Immunocytochemical analysis for GLT-1
in iAstrocytes.
(J) Quantification of GFAP, S100B, and GLT-
1-positive cells in iAstrocytes (ABS9) and
control fibroblasts. Cells nuclei are stained
with DAPI.
Data are expressed as means ± SEM. **p <
0.01. The scale bar represents 20 mm (C, F, H,
and I) and 100 mm (B, D, E, and G). Five
independent experiments are represented in
(J). See also Figures S1–S4.
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ESCs or NSCs. In line with this hypothesis, both Gfap
and S100b expression are gradually increased since the
first day after transgene activation (Figures S2J and S2K).
Despite that GFAP expression was undetectable in MEFs,
the STAT3-binding site on the Gfap promoter was often
found demethylated in bisulfite-sequencing analysis,
indicating that its repression is mediated by different
mechanisms rather than DNA methylation in these cells
(Figure S2L).
Subsequently, we analyzed the iAstro-proliferative capa-
bility, and indeed, a large fraction of iAstrocytes exhibited
some proliferative capacity as confirmed by the expression
of the cell-cycle marker Ki67 (Figures S3A–S3D) in expand-
ing clusters of reprogrammed cells. In fact, reprogrammed
cells could be passaged for at least eight times in the dish,
whereas most of them kept showing GFAP and S100B
immunoreactivity (Figures S3E and S3F).
To confirm their gliogenic-inducing activity, Nfia, Nfib,
and Sox9 were expressed in the developing cerebral cortex
by means of in utero electroporation. With this method,
cortical progenitors were targeted for exogenous gene
expression at an embryonic stage when they are exclu-
sively generating neurons. Mouse embryos were electropo-
rated at embryonic day 13.5 (E13.5), and targeted cortices
were analyzed at E18.5. Progenitors targeted for expressionStemof Nfia, Nfib, or Sox9 gene alone behaved similarly to
enhanced-GFP-electroporated control cells, being capable
of migrating radially in the cortical mantle and initiating
neuronal differentiation; in fact, the fraction of the GFP+
cells that remained out of the cortical plate (CP) was simi-
larly low in the four conditions (GFP 15.5% ± 2.3%; Nfia
13.2% ± 1.1%; Nfib 16.1% ± 2.9%; Sox9 13.2% ± 4.1%; Fig-
ures S4A–S4C, S4E–S4G, S4I–S4K, S4M–S4O, and S4Q–S4S;
data not shown). In contrast, expression of the ABS9 gene
combination arrested or delayed the migration of a signifi-
cant number of targeted progenitors (non-CP GFP+ cells
75.2% ± 6.4%; p < 0.001; arrows in Figure S4H) and some
of them strongly activated the expression of S100B (arrows
in Figures S4L, S4P, and S4T). The low percentage of tar-
geted cells expressing S100B (9.6% ± 3.4%) could be ex-
plained by the reduced probability of targeting each cell
with the four independent plasmids (ABS9 and GFP). How-
ever, it preserves high importance because the forced
expression of each single gene alone was insufficient to
ectopically activate S100B, indicating that the three factors
act synergistically to promote S100B expression in vivo.
These results demonstrate that the three factors NFIA,
NFIB, and SOX9 are capable and sufficient to activate a
mature astrocytic gene program both in skin fibroblasts
in vitro as well as in neuron fated-neuronal progenitors
in vivo.Cell Reports j Vol. 4 j 25–36 j January 13, 2015 j ª2015 The Authors 27
Figure 2. Transcriptional Profiling of iAstrocytes
(A) Microarray analysis comparison among noninfected MEFs (Fibro), induced astrocytes (iAstro), and primary cortical astrocytes (Astro).
(B) Hierarchical clustering of the analyzed samples shows a strong degree of correlation between iAstro and primary astrocytes.
(C–E) Scatterplot comparison between fibroblasts and iAstro shows that most of the astrocytic markers are increased in reprogrammed cells
(C), whereas other neural markers are unaltered (D) and some fibroblasts markers are silenced (E).
(F) Real-time RT-PCR analysis confirms that the expression of most astrocytic markers is comparable between iAstro and primary astro-
cytes.
Data are expressed as means ± SEM. *p < 0.05; **p < 0.01. Three independent experiments are represented in (F).
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Global Gene-Expression Profiling
To fully investigate the reprogrammed state of iAstrocytes,
we compared the global gene-expression pattern of MEFs,
iAstrocytes, as well as neonatal primary brain astrocytes
by microarray analysis. Considering that, during embry-
onic development, GFAP is also expressed inNSCs andneu-
ral precursors (Rowitch and Kriegstein, 2010), we could not
use the hGFAP-Cre;ROSA26-stop-flox-YFP mouse to derive
primary astrocytes. Thus, to avoid possible contamination
of YFP+/GFAP cells due to the transient embryonic GFAP
expression, we opted to derive astrocyte primary cultures
from the hGFAP-Cre mice that were subsequently infected
with the TET-O-FUW-flox-stop-flox-GFP construct in order
to timely activate the reporter in well-differentiated astro-
cytes. On the same line, to avoid any contamination due
to hGFAP promoter leakiness (Niu et al., 2013; data not
shown), iAstrocytes were reprogrammed from a GFP-nega-
tive-sorted MEF population. The heatmap comparison be-28 Stem Cell Reports j Vol. 4 j 25–36 j January 13, 2015 j ª2015 The AuthortweenMEFs, iAstrocytes, and native brain astrocytes clearly
showed that the iAstrocyte gene-expression signature was
close to that of primary astrocytes, although some clusters
of genes were still diverging (Figure 2A). The unbiased
hierarchical clustering also confirmed that iAstrocytes tran-
scriptional pattern segregated significantly closer to pri-
mary brain astrocytes than to MEFs (Figure 2B). When
our attention was focused on the comparison of specific
set of genes between MEFs and iAstrocytes, we observed
that most of the astrocyte-specific genes were strongly
upregulated in iAstrocytes (Figure 2C), whereas, at the
same time, genes strictly associated with other neural
lineages did not show evident upregulation (Figure 2D).
Noteworthy, many fibroblast-specific molecular markers
resulted evidently downregulated after astrocyte reprog-
ramming as shown in Figure 2E. Finally, to confirm micro-
array data, we performed an extensive qRT-PCR analysis for
several known astrocyte markers and confirmed that the
vast majority of them were significantly activated ins
Figure 3. Functional Characterization of
Induced Astrocytes
(A) Representative traces of ionic currents
evoked in mouse-cultured cortical astro-
cytes (Astro), iAstrocytes (iAstro), and fi-
broblasts (Fibro) using a ramp (left) and
voltage-step protocol (right). The stimula-
tion protocols are depicted as insets and
described in Experimental Procedures.
(B) Graph of resting membrane potential
values for the three cell types recorded
before the membrane current activation.
(C) Percentage of ramp current decrease
measured at +100 mV by application of 4-AP
(500 mM) in iAstrocytes, cortical astrocytes,
and fibroblasts.
(D) Representative Fura-2 responses trig-
gered by thrombin (3.5 U/ml) application
over time in astrocytes (gray trace), iAs-
trocytes (red trace), and fibroblasts (black
trace).
(E) The peak amplitudes of Fura-2 responses
and the t values of Ca2+ decay are shown as
means ± SEM of three independent experi-
ments (n > 50).
(F and G) Glutamate uptake assay. [3H]L-
glutamate cell content (F) and correspond-
ing glutamate levels in the medium (G).
**p < 0.01; ***p < 0.001.
Data are expressed as means ± SEM. Five
cells recorded in three independent experi-
ments are represented in (C) and (E). Three
independent experiments are represented in
(F) and (G).
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tween iAstrocytes and native brain astrocytes (Figure 2F).
Moreover, we found that even the three astroglial reprog-
raming factors ABS9 were endogenously upregulated in
iAstrocytes (Figure 2F), confirming a global activation of
the astrocytic transcriptional program.
iAstrocytes Share Critical Functions with Native Brain
Astrocytes
We next sought to determine whether iAstrocytes were en-
dowed with functional properties consistent with their
new reprogrammed cell state. To address this point, iAstro-
cytes electrophysiological properties were investigated by
patch-clamp recording. Given thatMEFs are a quite hetero-
geneous cell population where some neural progenitor
contaminants cannot be excluded, we opted for amore-ho-
mogeneous source of fibroblasts collected from the isolatedStemmouse postnatal dermis for the following experiments of
cell reprogramming. Initially, we compared fibroblasts, iAs-
trocytes, and native brain astrocytes for they ability to
generate K+ currents upon voltage stimulation. Ramp cur-
rents evoked in mouse cortical astrocytes and iAstrocytes
showed an outwardly rectifying profile at potentials more
positive than 40 mV (Figure 3A, left panel). This observa-
tion is in agreement with previous data indicating that
whereas rodent astrocytes in situ display a large inwardly
rectifying K+ conductance, which is developmentally regu-
lated (Kressin et al., 1995; Bordey and Sontheimer, 1997;
Zhou et al., 2006), primary cultured astroglial cells express
only large outward-rectifying K+ currents (Bevan and Raff,
1985; Ferroni et al., 1995). By contrast, fibroblasts exhibit
a small, linear membrane conductance in the whole range
of potentials tested, denoting the high membrane re-
sistance and the lack of any activation of voltage-gatedCell Reports j Vol. 4 j 25–36 j January 13, 2015 j ª2015 The Authors 29
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voltage-step protocol, typical outward K+ currents charac-
terized by rapid activation kinetics, partial slow inactiva-
tion, and a sustained component were evoked in astrocytes
and iAstrocytes, but not in fibroblasts (Figure 3A, right
panels). Currents evoked in iAstrocytes displayed a less-
prominent inactivation phase compared to brain astro-
cytes, a result that could be ascribed to a different state of
cell development (Bordey and Sontheimer, 1997). The pres-
ence of voltage-gated K+ currents in iAstrocytes was accom-
panied by a change in resting membrane potential (RMP)
that became significantly more negative than that of fibro-
blasts but still slightly more positive than the RMP
measured in primary cortical astrocytes (Figure 3B;
47.69 ± 3.71 mV, n = 26; iAstro: 36.15 ± 1.44, n = 20; fi-
broblasts:4.33 ± 0.39, n = 24). Consistent with the notion
that the outward current was a K+ conductance, the
voltage-gated currents in both astrocytes and iAstrocytes
were similarly depressed by about 50% by the K+ channel
blocker 4-aminopyridine (Figure 3C; 500 mM; astrocytes:
53% ± 3.37%, n = 4; iAstrocytes: 51.25% ± 3.47%, n = 5;
fibroblasts: 97.8% ± 1.09%, n = 5) that was previously re-
ported to inhibit by the same extent voltage-gated K+ chan-
nels in cultured astrocytes (Bordey and Sontheimer, 1997).
We also scrutinized iAstrocytes for their capacity to
generate intracellular calcium waves after thrombin appli-
cation. There is evidence, in fact, that astrocytes express a
protease-activated receptor (PAR), which is a G-protein-
coupled receptor activated by thrombin (Coughlin,
2000). In cultured astrocytes, PAR activation by thrombin
leads to robust Ca2+ mobilization involving inositol-
triphosphate-dependent intracellular Ca2+ release, which
promotes Ca2+ entry (Ubl and Reiser, 1997). PAR can be
activated by thrombin also in fibroblasts but generates
faster Ca2+ dynamics (Tanaka et al., 2003; Jeng et al.,
2004; Ro¨ssler and Thiel, 2009). We then performed Ca2+
imaging experiments using Fura-2/AM as ratiometric Ca2+
indicator in astrocytes, fibroblasts, and iAstrocytes by acti-
vating Ca2+ mobilization after application of human
thrombin (3.5 U/ml). In all experimental groups, thrombin
evoked a rising of intracellular Ca2+ but with substantial
main differences between fibroblasts and either astrocytes
or iAstrocytes (Figure 3D). Whereas the Ca2+ peak was
significantly higher and the t of Ca2+ decay was faster in fi-
broblasts, astrocytes and iAstrocytes displayed Ca2+ peaks
of lower amplitude and slower kinetics (Figure 3E). These
results, together with the previous electrophysiological
data, suggest that iAstrocytes and native astrocytes share
critical functions that are undetectable in the original pop-
ulation of primary fibroblasts before their genetic reprog-
ramming. Finally, we tested whether iAstrocytes exhibit
the capability of glutamate uptake, another critical prop-
erty of brain astroglial cells (Anderson and Swanson30 Stem Cell Reports j Vol. 4 j 25–36 j January 13, 2015 j ª2015 The Author2000). To quantitatively test glutamate uptake, fibroblasts,
iAstrocytes, and primary brain astrocytes were cultured in a
medium containing [3H]L-glutamate, and the radioactivity
in cellular extracts was quantified (n = 6). As shown in Fig-
ure 3F, iAstrocytes and brain astrocytes incorporated
similar levels of radioactivity that were significantly higher
than those present in cell lysates of fibroblasts. This result
was corroborated by the observation that the amount of
glutamate remaining in the bathing medium measured
by an enzymatic determination method was significantly
lower in the astroglial cells with respect to the fibroblasts
(n = 6; Figure 3G). These results indicate that both astroglial
cell types were similarly proficient in incorporating gluta-
mate. These data confirm that iAstrocytes develop an
intrinsic ability to uptake glutamate, demonstrating the
full functionality of the glutamate transporters. These find-
ings indicate that both native astroglial cells and iAstro-
cytes exhibit comparable capacity of glutamate uptake,
which ismuch lower in native fibroblasts. Altogether, these
assays denote that iAstrocytes possess functional properties
of primary astrocytes that are absent in the original
population of primary fibroblasts before their genetic
reprogramming.
iAstrocytes Undergo an Activated State when Exposed
to Cytokine Stimulation
Astrocytes are crucial for their role in the physiological ho-
meostasis of the CNS, but they are also known to take part
in the inflammatory response (Barres, 2008; Sofroniew and
Vinters, 2010; Sofroniew, 2014). Indeed, astrocytes retain
the ability to shift from a quiescent to an activated state
following the exposure to cytokines (Ridet et al., 1997). Cy-
tokines are key mediators of the inflammatory response in
the CNS, resulting, among others, in an increase of GFAP-
positive cells as well as in the activation of the NF-kB
pathway (Buffo et al., 2010; Moynagh, 2005). To test the
competence in responding to cytokine stimulation, we
treated dermal neonatal-derived iAstrocytes with inter-
leukin-1 (IL-1) for 24 hr and looked at the effects on cell
proliferation and theNF-kBmolecular pathway. Consistent
with the known astrocyte behavior (Ridet et al., 1997; Buffo
et al., 2010), IL-1 exposure resulted in an increased number
of cells positive for GFAP, but not for S100B, a protein
which is not associated with the astrocyte-activation pro-
cess (Figures 4A–4D). On the same line, the transcriptional
analysis revealed that IL-1 treatment in iAstrocytes induced
an increase in Gfap expression and a positive feedback of
cytokine expression as indicated by the increase of Il1
and interleukin-6 transcripts. iAstrocytes responded to
cytokine stimulus also by activating the NF-kB pathway,
as demonstrated by the significantly increased expression
of the molecular components Nfkb1, Nfkb2, and Nfkbia
(Figure 4E). These results stand as a proof of principles
Figure 4. Activation of iAstrocytes by Cy-
tokines
(A and B) Immunocytochemical analysis
shows that GFAP expression (A) is higher in
interleukin-1-stimulated (iAstro+Il1) than
in untreated iAstrocytes (iAstro), whereas
S100B expression (B) is not affected.
(C and D) Quantification of GFAP- and
S100B-positive cells (C) and staining in-
tensity (D) in control and Il1-treated cells.
AU, arbitrary units.
(E) Real-time RT-PCR analysis shows that
NF-kB pathway is significantly activated in
induced astrocytes after Il1 treatment. Cells
nuclei are stained with DAPI.
Data are expressed as means ± SEM. *p <
0.05; **p < 0.01. The scale bar represents
60 mm (A) and 30 mm (B). Four independent
experiments are represented in (C)–(E).
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uli and adapt their behavior to the surrounding environ-
mental conditions.
We finally asked whether the reprogrammed state of iAs-
trocytes remains stable after transplantation in vivo. To this
aim, we transplanted YFP-labeled iAstrocytes into the brain
parenchyma of neonatal mice and examined the grafted
brains 2 weeks after. Immunohistochemistry revealed the
presence of GFAP/GFP and S100/GFP double-positive cells
(Figures S5A–S5G), indicating that iAstrocytes are able to
survive and differentiate in the host brain over an extensive
time period. Grafted iAstrocytes organized in islands in the
transplanted site, and their spreading in the host tissue ap-
peared limited (Figures S5A and S5H). This is not surprising,
considering that native astrocytes are well known to release
high amounts of extracellular matrix (ECM) components,
which create a barrier to cell spreading (Dityatev and Rusa-
kov, 2011). In accordance with this hypothesis, we found
that grafted iAstrocytes are surrounded by a rich ECM
that confined the transplanted cells from the host tissue
(Figures S5H–S5J).
NFIA, NFIB, and SOX9Are Able to Induce anAstrocytic
Phenotype in Human Fibroblasts
Considering the huge implications of the potential genera-
tion of human iAstrocytes, we decided to test the ABS9-
reprogramming cocktail on human cells. Indeed, NFIA,
NFIB, and SOX9 are expressed in human fetal astrocytes
(Mense et al., 2006), and recently, NFI proteins have been
found among the transcription factors enriched in human
fetal astrocytes (Malik et al., 2014). Therefore, considering
that human reprogramming dynamics are substantially
slower, we infected human neonatal fibroblasts with ABS9
cocktail, keeping them activated for 3 weeks. Surprisingly,Stemthe following immunocytochemical analysis showed that a
small fraction of cells (2%) were coexpressing GFAP and
S100B with a typical pattern as normally detected in imma-
ture astrocytes, whereas no signal was revealed in not-in-
fected control (Figures 5A–5D). This experimental evidence
gives a clear proof of principle that the direct conversion of
human fibroblasts into iAstrocytes is possible, thus opening
opportunities in the field of human cell reprogramming.DISCUSSION
Altogether, this study demonstrates the possibility to
convert adult somatic cells such as dermal fibroblasts into
astroglial-like cells through the overexpression of only a
minimal set of the three factors NFIA, NFIB, and SOX9.
These results, together with previous reports, demonstrate
the possibility to reprogram mesodermal cells directly into
any of the three neuronal lineages including neurons (Vier-
buchen et al., 2010), oligodendrocytes (Najm et al., 2013;
Yang et al., 2013), and astrocytes (this report).
Our findings are corroborated by a previous report,
showing that NFIA and SOX9 associate in a protein com-
plex during the initial phases of gliogenesis in early devel-
opment (Kang et al., 2012). This study demonstrated that
NFIA and SOX9 form a transcriptional regulatory module,
which is necessary for the timely initiation of the gliogenic
process in the spinal cord anlage. Herein, we provided evi-
dence that these factors can even promote and sustain a
global astroglial gene program in mesodermal cells and
activate the expression of mature astrocytes markers such
as S100B, GLT1, ALDOC, and CD44 necessary to acquire
cardinal functional properties of mature astrocytes. In
support of these findings, the ABS9 gene combination isCell Reports j Vol. 4 j 25–36 j January 13, 2015 j ª2015 The Authors 31
Figure 5. Conversion of Human Fibroblasts into iAstrocytes
(A–C) Immunocytochemical analysis of GFAP and S100B in human
neonatal fibroblasts reprogrammed with NFIA, NFIB, and SOX9
(ABS9) for 3 weeks. The insets show higher magnification of typical
GFAP or S100B staining signals.
(D) Quantification of GFAP- and S100B-positive cells in ABS9 or NI
cells. Cells nuclei are stained with DAPI.
Data are expressed as means ± SEM. **p < 0.01. The scale bar
represents 50 mm. Three independent experiments are represented
in (D).
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Direct Conversion of Fibroblasts into iAstrocytescapable of suppressing the neuronal fate of early neural
progenitors while activating the expression of astroglial
markers.
iAstrocytes do not show any particular regional identity
in agreement with the pan-astroglial expression of all the
three reprogramming TFs. We can, however, speculate
that the addition of a fourth factor could be sufficient for
imposing a regional specification to the iAstrocytes that
may associate with the acquisition of supplementary and
region-specific functions (Pang et al., 2011; Yoo et al.,
2011). In the final part of the present work, we also pro-
vided a proof of principle that NFIA, NFIB, and SOX9 are
able to activate an astroglial program even in human
neonatal fibroblasts. Further experiments are needed to
prove the functional similarity to human astrocytes and
also to increase the low efficiency of conversion showed
by human fibroblasts. Nonetheless, these results lay the
ground for the future generation of human iAstrocytes.
If accomplished, these results would be of great interest
for biomedical applications. In fact, recent findings have
disclosed a previously unknown role of the astrocytic
compartment in the genesis and progression of an
increasing number of neurological disorders (Lioy et al.,
2011; Di Giorgio et al., 2008; Coulter and Eid, 2012;
McGann et al., 2012; Di Malta et al., 2012). Thus, the op-
portunity to have a fast way to generate high numbers of32 Stem Cell Reports j Vol. 4 j 25–36 j January 13, 2015 j ª2015 The Authorhuman astrocytes from patients will provide an extremely
versatile and informative cellular system for investigating
the pathophysiological processes in these cells. In addition,
transplantation of astrocytes has been found beneficial in
several disorders, including Parkinson’s disease and ALS
(Proschel et al., 2014; Lepore et al., 2008). This approach
does not aim at replacing a lost neuronal circuit but at de-
laying and restrainingneuronal dysfunctions and therefore
has less constrains and multiple potential applications.
Nowadays, the main perspective for an astrocyte cell-
replacement therapy is linked to the employment of iPSCs
that still share a lot of limitations due to their intrinsic ca-
pacity to generate tumors (Roy et al., 2006; Amariglio et al.,
2009). To our knowledge, this is the first evidence that
astrocyte-like cells can be derived from fibroblasts by
entirely skipping the iPSC generation. Therefore, our find-
ings represent a crucial step for the potential future applica-
tion of iAstrocytes in human disease biology and therapy.EXPERIMENTAL PROCEDURES
Cell Culture
MEFs were isolated from E14.5 wild-type or hGFAP-Cre;ROSA26-
flox-stop-flox-YFP mice embryos. Only forelimbs and forelegs
were taken, and the tissue wasmanually dissociated and incubated
in 0.25% trypsin (Sigma) for 10–15 min. Cells from each embryo
were plated onto a 15 cm tissue culture dish in MEF medium (Dul-
becco’s modified Eagle’s medium [Invitrogen], containing 10%
fetal bovine serum [Hyclone], b-mercaptoethanol [Sigma], nones-
sential amino acids [Invitrogen], sodium pyruvate, and peni-
cillin/streptomycin [Invitrogen]). In all experiments, cells were
not passaged more than four times. Postnatal fibroblasts were iso-
lated from dermis. Pups were sacrificed and skinned, and dermis
was isolated by overnight 0.25% trypsin treatment. Dermis was
then mechanically minced and dissociated with 0.25% trypsin
for 10–15min, placed on culture dishes, and grown inMEFmedia.
IL-1 (R&D Systems) 10 ng/ml was added for 24 hr to induce iAstro-
cytes stimulation. Human neonatal foreskin fibroblasts (ATCC;
PCS-201-010) were grown in MEF medium.
Molecular Cloning and Viral Infection
cDNAs for the astrocytic transcription factors were cloned into
lentiviral vectors under the control of the tetracycline operator.
Replication-incompetent, VSVg-coated lentiviral particles were
packaged in 293T cells. MEFs or postnatal mouse fibroblasts were
infected in MEF medium using each virus at 25 multiplicity of
infection. Sixteen to twenty hours after infection, cells were
switched into fresh MEF media containing doxycycline (2 mg/ml;
Sigma). After 24 hr, doxycycline was added to the medium. The
medium was changed every 2 or 3 days for further 12–16 days.
Cell Sorting and Microarray Analysis
GFAP-YFP-positive iAstrocytes were sorted using the cell sorter
FACSVantage SE. DiVa (Becton Dickinson) and RNA was extracted
with RNeasy Plus Mini Kit (QIAGEN). GeneChip Mouse Genomes
Stem Cell Reports
Direct Conversion of Fibroblasts into iAstrocytes430A 2.0 Arrays (Affymetrix) were hybridized with cRNA. Microar-
ray data were preprocessed using Bioconductor package Affy (Gaut-
ier et al., 2004) and normalized using robust multiarray average
method (Irizarry et al., 2003). Differentially expressed genes among
iAstrocytes, primary postnatal cortical astrocytes, and MEFs were
identified through a one-way ANOVA using one factor with three
levels (iAstro/primary postnatal cortical astrocyte [PPCA]/MEF). p
values were corrected for multiplicity according to the Benja-
mini-Hochberg procedure (false discovery rate [FDR]; Benjamini
and Hochberg, 1995). The threshold used for the FDR was 0.05.
The differentially expressed genes between conditions (iAstro
versus MEF, PPCA versus MEF, and iAstro versus PPCA) were
analyzed using the post hoc Tukey multiple comparisons test (p
value < 0.05). Results were further filtered by change magnitude
(jfold changej R 2), and the differentially expressed genes were
classified on the basis of the comparison tests they have passed.Electrophysiology
After 12 days of reprograming, cells were plated at density of 1 or 2
3 104 onto 33 mm Petri dishes after trypsin-EDTA enzymatic
dispersion and electrophysiological recordings were made 2–
4 days later. Membrane currents were recorded using the whole-
cell configuration of the patch-clamp technique, as previously
described (Ferroni et al., 1995; Valente et al., 2011). Patch pipettes
prepared from thin-walled borosilicate glass capillaries (Hilgenberg)
were pulled and fire-polished to have a tip resistance of 3 or 4 MU
when filled with standard internal solution. Data were sampled at
10 kHz (double EPC-10 amplifier with Pulse software; HEKA Elec-
tronic) and low-pass filtered at 3 kHz for analysis (Fitmaster 2.73;
HEKA). The series resistance was usually <10 MU and to minimize
voltage errors was compensated to 60%–80%. Recordings with
leak currents >100 pA were discarded. All measurements were per-
formed at room temperature (20C–24C). The protocols of voltage
stimulation consisted of either a repetitive protocol that, from the
holding potential (Vh) of60mV, stepped themembrane potential
to 100 mV for 200 ms before a 100 ms long depolarizing ramp
to +120 mV or a voltage-step family with 200 ms steps from
100 mV to +120 mV in 20 mV increments from the Vh of
60 mV. The interval between each pulse in both protocols was
10 s. Membrane capacitances and current values recorded at the
end of the linear ramp were used to calculate current densities.
The resting membrane potential was measured 2 min after estab-
lishing the whole-cell recording configuration using the amplifier
analog circuit. Recordings were made by superfusing the clamped
cell with a standard bath saline solution containing (in mM): 140
NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, 10 HEPES, 5 glucose (pH 7.4) with
NaOH, and osmolality adjusted to 315 mOsm kg1 with mannitol.
The intracellular pipette solution contained (in mM): 144 KCl, 2
MgCl2, 5 EGTA, 10 HEPES (pH 7.2) with KOH, and osmolality of
300 mOsm kg1 with mannitol. The extracellular solution was
applied by gravity-driven microperfusion system at flow rate of
about 200 ml/min located near (z100 mm) the cell under study.Calcium Imaging
Astrocytes, iAstrocytes, and fibroblasts were loaded with Fura-2,
AM (5 mM; Molecular Probes) for 1 hr at 37C, 5% CO2 in culture
medium. Coverslips were mounted on the stage of an IX-71 in-Stemverted microscope (Olympus) equipped with a monochromator
(Polychrome V; TILL Photonics). Cells were imaged in in standard
bath saline solution containing (in mM): 2 CaCl2, 140 NaCl, 1
MgCl2, 10 HEPES, 4 KCl, 10 glucose (pH 7.3), and 300 mOsm
kg1 by using a cooled charge-coupled device camera (ANDOR;
iXon 897) and sampling at 0.5 Hz with a 40 objective (0.95 numer-
ical aperture). After 2min baseline, 3.5 U/ml human thrombinwas
added to the bath. The offline analysis of the fluorescent intensities
ratio at 340 and 380 nm was performed with the TILL-vision soft-
ware and normalized to the baseline.
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